Welcome to our dedicated page for Univ Health Svc SEC filings (Ticker: UHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Universal Health Services, Inc. filings document the financial results, governance practices and capital structure of a healthcare-services company operating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points through subsidiaries. Form 8-K reports include operating and financial results, material agreements, credit-facility disclosures and other corporate events.
UHS proxy materials cover shareholder voting matters, board oversight, executive compensation and incentive-plan arrangements. The company’s regulatory disclosures also address risk factors, legal proceedings, ownership and governance matters, and capital actions such as share repurchases, dividends and financing arrangements.
UNIVERSAL HEALTH SERVICES INC Executive Chairman Alan B. Miller reported internal transfers and trust distributions of Class B Common Stock with no open-market trading. On May 27, 2026, several grantor retained annuity trusts (GRATs) distributed shares to Miller, while he also transferred shares from his direct holdings into new 2026 GRATs.
Footnotes state that distributions such as 13,963, 9,418 and 14,163 Class B shares from various 2024 and 2025 GRATs left his pecuniary interest unchanged, indicating these were structural movements rather than economic purchases or sales. After the reported J-code transactions, Miller’s direct holdings are shown as 1,810,129 Class B shares, alongside multiple indirect positions in family trusts and foundations, some of which he disclaims beneficial ownership of.
Universal Health Services, Inc. reported the results of its 2026 Annual Meeting of Stockholders held virtually on May 20, 2026. Stockholders elected Alan B. Miller as a Class III director with 7,236,288 votes in favor and no votes withheld, and elected Nina Chen-Langenmayr with 31,836,231 votes in favor and 14,129,963 votes withheld.
Stockholders approved, on an advisory basis, the compensation of the company’s named executive officers, with 62,219,230 votes in favor and 228,600 against. They also ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 62,633,332 votes in favor.
A stockholder proposal requesting reporting of votes based on UHS shareholder money at risk was rejected, receiving 2,917,981 votes in favor and 59,513,156 against. A separate workforce diversity disclosure proposal was withdrawn before the meeting and therefore was not voted on.
Chen-Langenmayr Nina reported acquisition or exercise transactions in this Form 4 filing.
UNIVERSAL HEALTH SERVICES INC director Nina Chen-Langenmayr received an equity award of 1,217 shares of Class B Common Stock. The shares were granted as restricted stock units with a grant price of $0.00 per share, bringing her direct holdings to 4,267 shares after the award.
The restricted stock units were granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units are scheduled to vest on the earlier of May 20, 2027, or the next annual meeting of stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting.
SUSSMAN ELLIOT J MD MBA reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services director Elliot J. Sussman received an equity grant in the form of restricted stock units of the company’s Class B Common Stock. He was awarded 1,217 restricted stock units, which increased his direct holdings to 7,330 shares after the transaction.
The grant was made at no cash cost to Sussman and was issued under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units are scheduled to vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the 2026 annual meeting date of May 20, 2026.
Universal Health Services director Eileen C. McDonnell received an equity grant under the company’s incentive plan. On May 20, 2026, she acquired 1,217 shares of Class B Common Stock at a stated price of $0.00 per share, increasing her direct holdings to 9,406 shares.
The footnote explains that the award consists of restricted stock units granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that is at least 50 weeks after the May 20, 2026 annual meeting date.
Singer Maria Ruderman reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services director Maria Ruderman Singer received a grant of 1,217 shares of Class B Common Stock as a stock award, with no cash paid per share. After this grant, she directly holds 9,792 Class B shares.
The award consists of restricted stock units granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units will vest on the earlier of May 20, 2027 or the next annual stockholder meeting that occurs at least 50 weeks after the May 20, 2026 annual meeting.
Nimetz Warren J. reported acquisition or exercise transactions in this Form 4 filing.
UNIVERSAL HEALTH SERVICES INC director Warren J. Nimetz received an award of 1,217 shares of Class B Common Stock in the form of restricted stock units at no cash cost. The units were granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.
All units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting date. Following this award, Nimetz directly holds 9,698 shares of Class B Common Stock.
Universal Health Services, Inc. announced that Matthew J. Peterson, Executive Vice President and President of Behavioral Health, has resigned effective June 19, 2026. He has been with the company since 2019 and plans to pursue a non-competitive external opportunity.
As of the effective date, all of his unvested stock options, restricted stock units and performance-based restricted stock units will terminate. After that date, he will receive only amounts already accrued and vested under company benefit plans and any payments required by law.
Chief Executive Officer and President Marc D. Miller will take on interim leadership of the Behavioral Health Care Division alongside its Senior Vice Presidents, while the company begins an immediate search for a permanent replacement.
Universal Health Services reported higher results for the quarter ended March 31, 2026. Net revenues rose to $4.50 billion from $4.10 billion a year earlier, with growth in both acute care and behavioral health segments, including its U.K. operations.
Net income attributable to UHS increased to $348.7 million, and diluted EPS grew to $5.65 from $4.80. Operating cash flow was strong at $401.6 million, funding $217.2 million of capital spending while total debt stood around $4.7 billion.
The company expanded its credit capacity by $900 million and agreed to acquire Talkspace, Inc. for about $835 million, to be financed under its credit facility. However, it faces significant legal exposure, including the Cumberland Litigation, and its Laurel Ridge Treatment Center has been terminated from Medicare and Medicaid, which is expected to drive operating losses during recertification efforts.
Universal Health Services Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,922,926 shares of Common Stock, representing 7.28% of the class as reported with an ownership date of 03/31/2026. The filing states Vanguard exercises sole dispositive power over those shares and identifies 470,041 shares as subject to sole voting power. The filing is made on behalf of Vanguard and affiliated advisory units and is signed on 04/30/2026.